Antifibrinolytic proCPU is present in the peritoneal cavity during surgery

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 4, 2003, Pages 287-296

  Falk, Kristina ^a,c   Bjorquist P ^b   Falk, P ^a   Hedgren, M ^a   Ivarsson, M L ^a   Lanne, B ^b   Panfilov, O ^b   Holmdahl, L ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Carboxypeptidase U; Fibrinolysis; Peritoneum; Surgery; Thrombin activatable fibrinolysis inhibitor

Indexed keywords

ENZYME PRECURSOR; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; FIBRIN CLOT; FIBRIN DEPOSITION; FIBRINOLYSIS; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MESOTHELIUM CELL; PERITONEAL BIOPSY; PERITONEAL CAVITY; PERITONEAL FLUID; PERITONEUM ADHESION; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROSA; SURGERY; SURGICAL INJURY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; WOUND HEALING;

EID: 0042232479     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310001726     Document Type: Article

References (22)

1. Menzies D. Postoperative adhesions: their treatment and relevance in clinical practice. Ann R Coll Surg Engl 1993; 75: 147-53.
2. Van Der Krabben AA, Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, Schaapveld M, Van Goor H. Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg 2000; 87: 467-71.
3. Holmdahl L, Eriksson E, al-Jabreen M, Risberg B. Fibrinolysis in human peritoneum during operation. Surgery 1996; 119: 701-5.
4. Sakharov DV, Plow EF, Rijken DC. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. J Biol Chem 1997; 272: 14477-82.
5. Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996; 271: 16603-8.
6. Marx PF, Wagenaar GT, Reijerkerk A, Tiekstra MJ, van Rossum AG, Gebbink MF, Meijers JC. Characterization of mouse thrombin-activatable fibrinolysis inhibitor. Thromb Haemost 2000; 83: 297-303.
7. van Hinsbergh VWM, Kooistra T, Scheffer MA, van Bockel JH, van Muijen GNP. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490-7.
8. Ivarsson ML, Falk P, Holmdahl L. Response of visceral peritoneum to abdominal surgery. Br J Surg 2001; 88: 148-51.
9. Stromqvist M, Schatteman K, Leurs J, Verkerk R, Andersson JO, Johansson T, Scharpe S, Hendriks D. Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma. Thromb Haemost 2001; 85: 12-7.
10. Lanne B, Potthast F, Höglund Å, Brockenhuus von Lövenhielm H, Nystrom A-C, Nilsson F, Dahllöf B. Thiourea enhances mapping of the proteome from murine white adipose tissue. Proteomics 2001; 1: 819-28.
11. Schatteman KA, Goossens FJ, Scharpe SS, Hendriks DF. Proteolytic activation of purified human procarboxypeptidase U. Clin Chim Acta 2000; 292: 25-40.
12. Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B. Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 1998; 58: 195-203.
13. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS, Chegini N. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 1996; 81: 3222-30.
14. Bouma BN, Marx PF, Mosnier LO, Meijers JC. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). Thromb Res 2001; 101: 329-54.
15. Schatteman KA, Goossens FJ, Scharpe SS, Neels HM, Hendriks DF. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma. Clin Chem 1999; 45: 807-13.
16. van Tilburg NH, Rosendaal FR, Bertina RM. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 2000; 95: 2855-9.
17. van Goor H, Bom VJ, van der Meer J, Sluiter WJ, Bleichrodt RP. Coagulation and fibrinolytic responses of human peritoneal fluid and plasma to bacterial peritonitis. Br J Surg 1996; 83: 1133-5.
18. Boffa MC, Burke B, Haudenschild CC. Preservation of thrombomodulin antigen on vascular and extravascular surfaces. J Histochem Cytochem 1987; 35: 1267-76.
19. Mosnier LO, Meijers JC, Bouma BN. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb Haemost 2001; 85: 5-11.
20. Hellebrekers BW, Trimbos-Kemper GC, Bakkum EA, Trimbos JB, Declerck PJ, Kooistra T, Emeis JJ. Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation. Thromb Haemost 2000; 84: 876-81.
21. Siebenlist KR, Mosesson MW. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis. J Biol Chem 1994; 269: 28414-9.
22. Nagashima M, Werner M, Wang M, Zhao L, Light DR, Pagila R, Morser J, Verhallen P. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model. Thromb Res 2000; 98: 333-42.